Johnson & Johnson (JNJ) earnings Q3 2026 – USFTB
Johnson & Johnson reported a slightly higher-than-expected profit on Tuesday, driven by strong sales of immune disease treatment Tremfya, but geopolitical issues, including the Middle East conflict, were a drag on its medical devices business.…
Read MoreUnitedHealth shares are doing something unusual ahead of earnings
The only thing more expensive than health insurance is perhaps the costs of insuring shares of health insurers. Case in point: UnitedHealth Group, which reports earnings Tuesday. Implied volatility is running at twice realized volatility ahead of the…
Read More